Offer - Urjas Oil for just ₹ 1
Alprazone 0.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Alprazone 0.25 Tablet is used -
Severe
Moderate
Mild
Is the use of Alprazone 0.25 Tablet safe for pregnant women?
Alprazone shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Alprazone 0.25 Tablet safe during breastfeeding?
Alprazone may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Alprazone 0.25 Tablet on the Kidneys?
Very few cases of side effects of Alprazone on kidney have been reported.
What is the effect of Alprazone 0.25 Tablet on the Liver?
There may be severe side effects of Alprazone on your liver. Do not take it unless a doctor says so.
What is the effect of Alprazone 0.25 Tablet on the Heart?
Very few cases of side effects of Alprazone on the heart have been reported.
Alprazone 0.25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Alprazone 0.25 Tablet unless your doctor advises you to do so -
Is this Alprazone 0.25 Tablet habit forming or addictive?
You may get addicted to Alprazone 0.25 Tablet. Therefore, before taking it, consult your doctor.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Alprazone 0.25 Tablet. So it is best to avoid driving.
Is it safe?
Yes, Alprazone 0.25 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Alprazone 0.25 Tablet has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Alprazone 0.25 Tablet
When consumed with certain foods, Alprazone 0.25 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Alprazone 0.25 Tablet
Taking Alprazone 0.25 Tablet and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
Alprazone can be taken with or without food. Preferably taken 2 - 4 times in a day. Extended-release tablet should be taken once daily. The dose should be gradually increased from low to high. It may cause dizziness and drowsiness which altered the thinking power of people. You shouldn't drive or operate heavy machinery while taking medicine. However, take it exactly as your doctor has recommended you to take it.
Stopping or discontinuing Alprazone on your own can cause withdrawal symptoms (seizures, difficulty in sleep, headache, nervousness, and depression). However, if you decide to stop/discontinue it, then stop it slowly, do not stop suddenly. However, please do not hesitate to discuss with your doctor if you are experiencing any withdrawal symptoms after stopping/discounting it on your own.
No, Alprazone does not cause weight gain. However, if you gain weight after taking Alprazone, discuss it with your doctor.
Yes, Alprazone can be taken with Tylenol. No clinical significance interactions have been reported between them. However, if you experience any undesirable effects after consuming these two medicines at the same do not hesitate to inform the doctor.
Yes, Alprazone can cause low blood pressure if taken in higher doses. However, the exact cause behind this is unknown.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; XANAX® alprazolam
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 405
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 129-131
